Solvay

Solvay is a Belgium-based international chemical company that specializes in the production of basic chemicals, plastics, and composites. Its product offerings include essential chemicals such as soda ash, hydrogen peroxide, and sodium bicarbonate, as well as high-value specialty polymers and aerospace composites. The company operates through several key business segments, including Basic Chemicals, Performance Chemicals, and Corporate. Solvay is recognized for its innovative solutions that address social, environmental, and industrial challenges, with materials designed to withstand demanding conditions in various industries, including aerospace and medical applications. With a balanced geographical presence, the company generates sales from Europe, North America, and Asia, securing a top-three market position for nearly all its products.

Coppelia Marincovic

Solvay Ventures - Investment Manager North America

18 past transactions

Solid Power

Series A in 2018
Solid Power Inc. specializes in the development of solid-state rechargeable batteries that are free from volatile or flammable liquid components. Founded in 2011 and based in Louisville, Colorado, the company focuses on creating batteries for various applications, including electric vehicles, portable electronics, aircraft, and satellites. Its solid-state batteries are designed to be energy-dense, safe, and reliable, offering significant improvements in performance, safety, and cost-effectiveness. Solid Power aims to license its battery cell designs and manufacturing expertise to leading battery manufacturers and automotive original equipment manufacturers, while also selling its proprietary sulfide-based solid electrolyte for use in all-solid-state battery cells.

European Carbon Fiber

Acquisition in 2017
European Carbon Fiber GmbH manufactures precursors for the carbon fiber industry.

MultiMechanics

Seed Round in 2017
MultiMechanics provides virtual testing software that empowers engineers to solve the world's most complex material engineering challenges. Our flagship product, MultiMech, enables innovation in complex materials and is used by leading companies in several industries, including aerospace, automotive, and consumer products, to save millions of dollars in product development costs.

Nohms Technologies

Series B in 2016
NOHMs Technologies is developing materials and manufacturing processes for advanced lithium-ion battery electrolyte that enables twice the energy and runtime for half the cost in consumer electronics and electric vehicles via sales and licensing business model. The company's NanoLyte Electrolyte solutions contain new functional ionic liquid materials that significantly improve the performance and safety of next-generation lithium-ion batteries. NOHMs Technologies was founded in 2011 and is headquartered in Rochester, New York, United States.

Ryton

Acquisition in 2015
Ryton® PPS resin manufacturing units in Borger, Texas, a pilot plant and R&D laboratories in Bartlesville, Oklahoma, as well as a compounding plant in Kallo-Beveren, Belgium.

Dhaymers Quimica Fina Ltda

Acquisition in 2014
Dhaymers Quimica Fina Ltda produces esters and used as ingredients in skin care market.

Plextronics

Acquisition in 2014
Plextronics specializes in the development of printed electronics, focusing on organic light-emitting diode (OLED) displays and lighting. The company creates conductive inks and associated process technologies that facilitate the mass production of printed devices, thereby reducing costs. Additionally, Plextronics is involved in the development of active layer technology for organic solar cells and plastic circuitry, further enhancing its portfolio in the realm of advanced electronic materials.

Next Energy Technologies

Non Equity Assistance in 2013
Next Energy Technologies specializes in transparent photovoltaic technology that enables windows to generate electricity from sunlight. Their innovative nano-coating converts ultraviolet and infrared light into usable energy, allowing buildings to produce renewable energy on-site and contribute to net-zero energy goals. This technology maintains transparency and efficiency, even in challenging lighting conditions, and is integrated directly into dual-pane windows, which reduces additional encapsulation costs. By transforming traditional windows and glass facades into energy-generating surfaces, Next Energy Technologies offers a cost-effective solution for enhancing building sustainability and reducing reliance on conventional energy sources.

Sunshield Chemicals Ltd

Acquisition in 2012
Sunshield Chemicals Limited manufactures and sells specialty chemicals in India, the United States, Europe, and the Far East.

Polyera

Series C in 2012
Polyera Corporation is a technology company based in Skokie, Illinois, specializing in the development of flexible transistor technologies and materials for the printed and flexible electronics industry. Founded in 2005, Polyera focuses on creating innovative solutions that enable advanced electronics manufacturing processes and novel product designs. Their portfolio includes ActivInk products, which facilitate the production of lightweight and adaptable electronic devices, such as wearable technology, mobile displays, and Internet of Things applications. These advancements transform interactions across various sectors, including supply chain, retail, and healthcare. Polyera collaborates closely with clients to provide tailored technical support, ensuring the successful commercialization of cutting-edge printed and flexible electronic products that can be integrated into multiple applications, from consumer electronics to automotive and aerospace industries.

Polyera

Series B in 2010
Polyera Corporation is a technology company based in Skokie, Illinois, specializing in the development of flexible transistor technologies and materials for the printed and flexible electronics industry. Founded in 2005, Polyera focuses on creating innovative solutions that enable advanced electronics manufacturing processes and novel product designs. Their portfolio includes ActivInk products, which facilitate the production of lightweight and adaptable electronic devices, such as wearable technology, mobile displays, and Internet of Things applications. These advancements transform interactions across various sectors, including supply chain, retail, and healthcare. Polyera collaborates closely with clients to provide tailored technical support, ensuring the successful commercialization of cutting-edge printed and flexible electronic products that can be integrated into multiple applications, from consumer electronics to automotive and aerospace industries.

Plextronics

Series B in 2009
Plextronics specializes in the development of printed electronics, focusing on organic light-emitting diode (OLED) displays and lighting. The company creates conductive inks and associated process technologies that facilitate the mass production of printed devices, thereby reducing costs. Additionally, Plextronics is involved in the development of active layer technology for organic solar cells and plastic circuitry, further enhancing its portfolio in the realm of advanced electronic materials.

Innogenetics

Acquisition in 2008
Innogenetics NV develops and markets diagnostic products for therapy management and patient health. Its diagnostics business focuses on developing products for infectious diseases, genetic testing, tissue typing, neurodegeneration, and oncology. Its products in the area of infectious diseases include screening and confirmation tests for HIV, HCV, HTLV, and syphilis; genotyping tests for hepatitis B virus (HBV), human papillomavirus, and mycobacterium sp; and drug-resistance tests for TB and HBV. Innogenetics also offers genetic testing products comprising detection tests for cystic fibrosis, as well as MBL2 and APO E genetic variants associated with genetic risks; tissue typing tests to determine the type of HLA; and neurodegeneration products, which include tests for Alzheimer's disease. In the Oncology area, the company distributes AdnaGen AG’s diagnostics products for breast and colon cancer. Its therapeutics business engages in the development of therapeutic vaccines for the treatment of infectious diseases caused by hepatitis C, hepatitis B, and human papillomaviruses. The company’s therapeutic portfolio includes GNI-102, a polyepitope vaccine candidate, which is in phase I clinical trial targeting HBV; GNI-104, which are anti-HCV neutralizing human monoclonal antibodies; and GNI-105, a HPV polyepitope vaccine candidate. It has collaborative research, development, distribution, or licensing agreements with Solvay Pharmaceuticals BV; sanofi-aventis; Takeda Chemical Industries; Immuno-Biological Laboratories Co; Roche Group of companies; AdnaGen AG; Siemens Healthcare Diagnostics; Danisco A/S; Pharmexa-Epimmune, Inc.; and PamGene International BV. It sells its products primarily in Germany, Italy, France, Spain, the United States, Brazil, Switzerland, Austria, the Benelux, and Eastern Europe. It was founded in 1985 and is based in Gent, Belgium. As of November 20, 2008, Innogenetics NV operates as a subsidiary of Solvay Pharmaceuticals S.A.

Plextronics

Series B in 2007
Plextronics specializes in the development of printed electronics, focusing on organic light-emitting diode (OLED) displays and lighting. The company creates conductive inks and associated process technologies that facilitate the mass production of printed devices, thereby reducing costs. Additionally, Plextronics is involved in the development of active layer technology for organic solar cells and plastic circuitry, further enhancing its portfolio in the realm of advanced electronic materials.

Solvay Specialty Polymers Italy

Acquisition in 2002
Solvay Specialty Polymers Italy S.p.A. manufactures and supplies plastic products, polymer films and sheets for customers in Italy and internationally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.